Theophylline affects sleep-wake state development in premature infants

Area of Science:

• Neonatal development
• Developmental neuroscience
• Pharmacology

Background:

• Apnea of prematurity is a common condition in preterm infants.
• Theophylline is a medication used to treat apnea of prematurity.
• Understanding the long-term effects of neonatal medication is crucial for infant health.

Purpose of the Study:

• To investigate the prolonged effects of theophylline on infant state behavior.
• To determine if theophylline's impact on state organization persists after drug clearance.

Main Methods:

• Compared sleep-wake states in three groups of infants: preterm infants previously treated with theophylline, preterm infants never treated with theophylline, and normal full-term infants.
• Observed sleep-wake states in the home for seven-hour periods at corrected ages of 2, 3, 4, and 5 weeks post-term.
• Analyzed data from periods when infants were alone to assess state organization.

Main Results:

• The theophylline-exposed group showed significantly different state organization compared to the other two groups.
• The theophylline group exhibited more non-alert waking, alert, and drowsy/transition states, and less active sleep.
• No significant differences were found between the non-theophylline preterm and full-term infant groups.

Conclusions:

• Theophylline administration appears to alter the normal development of state organization in premature infants.
• These observed behavioral effects persisted long after the theophylline had cleared from the infants' systems.
• Findings suggest potential long-term neurodevelopmental impacts of theophylline in preterm infants.